Latest media releases
UBS Global Life Sciences Conference Opens in New York
The Tenth Annual UBS Global Life Sciences Conference begins today at the Grand Hyatt in New York City and continues through Thursday, September 25. The Conference will feature presentations by more than more than 300 public and private companies including biotechnology, medical device manufacturers, pharmaceuticals and specialty pharmaceutical companies.
The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry.
Actelion Pharmaceuticals Ltd.
Alexion Pharmaceuticals Inc
Applied Biosystems Inc.
Boston Scientific Corporation
Charles River Laboratories
Dentsply International Inc.
Eli Lilly & Co.
F. Hoffmann - La Roche Ltd.
Gilead Sciences, Inc.
Glenmark Pharmaceuticals Ltd.
IMS Health Inc.
Inverness Medical Innovations
Laboratory Corporation of America
Mettler Toledo International Inc.
Myriad Genetics, Inc.
Nobel Biocare AB
Onyx Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc.
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
Sonova Holding AG
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific Corp
United Therapeutics Corporation
Vertex Pharmaceuticals Incorporated
Online conference information
To access audio transmissions and the conference agenda please go to the UBS Investment Bank website at www.ibb.ubs.com. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for a period of four weeks.
UBS is one of the world's leading financial firms, serving a discerning international client base. UBS is a leading global wealth manager, a leading global investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking.
UBS is present in all major financial centers worldwide. It has offices in over 50 countries, with about 37% of its employees working in the Americas, 34% in Switzerland, 16% in the rest of Europe and 13% in Asia Pacific. UBS employs more than 80,000 people around the world. Its shares are listed on the Swiss Stock Exchange (SWX), the New York Stock Exchange (NYSE) and the Tokyo Stock Exchange (TSE).
New York , September 22, 2008